Shopping Cart
Your Cart is Empty
There was an error with PayPalClick here to try again
CelebrateThank you for your business!You should be receiving an order confirmation from Paypal shortly.Exit Shopping Cart

Terave Shetland


"Perm. Reg'd"

                                  Sable litter due April 10th, 2023

Bi-factored sable puppies expected April 10th from "Tirian" and "Wicca" .

Our puppies sell for $1200.00 for companions

and are ready for their new homes at 9-10

weeks. Older puppies and dogs will

range from $800.00 to $1200.00

   Sorry, we do not ship puppies.

All puppies are CKC registered, current on

vaccinations, dewormed, micro chipped and come

with 6 weeks of health Insurance

and are health guaranteed for 3 years.  

Companion puppies are sold on a strict spay/neuter contract

Please note that I reserve the right to refuse any sale at my discretion, if I feel it is not the right placement for one of my dogs.

Sheltie Health info and testing we do on our shelties.

Von Willebrand’s Disease: A common bleeding disorder seen in many breeds of dogs.

Why so Important? - If you buy a pet puppy affected with Vwd, Getting the dog/bitch, fixed may cause them to die. If there is no coagulation of blood, there is a risk animal could bleed to death.

More Info:

Hereditary eye disease: Detailed diagnoses by veterinary ophthalmologists. There are hereditary diseases, prominent in specific breeds. There is an organization and database specifically for Canine eye disease called the Canine Eye Registry Foundation.

For eye disorders and classifications please visit

Thyroid Disease: Abnormal levels of thyroid hormones found in blood serum. Classifications and hormone levels may vary. Some may include Hypothyroidism, hyperthyroidism, and autoimmune thyroiditis. Symptoms may vary (may include weight and coat abnormalities.) (

more info:

Multi-Drug Sensitivity Resistance Gene (MDR1): Mutation of a gene preventing specific toxins from being efficiently removed from the brain.

Why so important? - Toxicity of certain drugs can cause neurological damage and even death. Some common de-worming medications may include a drug that can cause toxicity and the death of your pet. There are several specific drugs to be weary of, AND HERE when dogs are AFFECTED (mutant/mutant) or have CARRIER status (Mutant/Normal) THEY CAN BE mildly affected by specific drugs. (NOTE: this is not the case with Vwd. Carrier individuals with Vwd do not have ANY coagulation impediments.)

More info:

Dermatomyositis (DMS)

Dermatomyositis (DMS)* is an autoimmune disease of the skin and muscle that occurs in both humans and dogs. In dogs, DMS is most often diagnosed in Shetland Sheepdogs and Collies and is caused by a combination of environmental and genetic factors. Skin lesions consist of hair loss and crusts on areas with minimal muscle overlying the bone such as the face, ear tips, legs and feet, and the tip of the tail. Muscle involvement is uncommon in Shelties. Onset of lesions may occur as early as 12 weeks of age or in mature dogs. In some affected puppies, lesions may diminish with age and may or may not return at an older age. Stress may induce worsening of lesions. Definitive diagnosis can only be made with a skin biopsy. Treatment with pentoxyphyline (Trental®), corticosteroids, and vitamin E has been helpful in some dogs**.

Bardet–Biedl syndrome-2 gene (BBS2- PRA) 

In 2021, British researchers reported on a mutation that causes Progressive Retinal Atrophy (PRA) in Shetland Sheepdogs called BBS2-PRA [1,2]. This is a different PRA causing mutation than CNGA1-PRA reported in 2015 [3], and for which DNA testing has been available for several years.

Along with PRA, BBS2-PRA affected dogs have physical characteristics that include an upturned nose, an unusual coat texture which is wavy, and dental defects* and possibly kidney disease [Figures 1 & 2]. The phenotypic changes are recognizable at an early age and become increasingly noticeable as the dogs develop becoming more apparent around 6 months of age. The condition is comparable to a syndrome in humans called Bardet Biedl (pronounced BAR-day BEED-el) syndrome. The mutation has not been found in other breeds.

In both forms of PRA, carriers are normal and only those homozygous for the mutation (have 2 copies of the mutation) are affected.

Initially, it was believed that the mutation for BBS-2 was confined to European Shelties; however, since Wisdom Health and Animal Genetics, Inc. have included the test in their panels, the mutation has been found in US bred Shelties. Over 50 U.S. Shelties tested by Wisdom Health were carriers of the mutation and an additional Sheltie was homozygous (affected). Since Animal Genetics began testing for the mutation around the fall of 2022, the Committee Chair learned, through personal communication, that carriers of the mutation have been found in the U.S. show population. The Chair has been unable to obtain any information regarding the numbers of Shelties with the BBS2-PRA mutation from Animal Genetics, Inc.

Since the phenotypic changes of the unusual facial features and long wavy coats are easily identified, why haven’t we Sheltie breeders in the U.S. been aware of the problem? Possible explanations include:

1) The overall number of dogs with the mutation is likely very low.

2) It is likely that affected dogs are identified at an early age as not being show prospects and are placed in pet homes.

3) The age of onset of visual problems appears to be close to 9 years of age (one in the study was about 6-years-old). Affected dogs initially had reduced vision in low light conditions before a noticeable decline in daylight vision occurred [3].

4) Owners of pet dogs may be less inclined to have their dogs examined by a veterinary ophthalmologist and may attribute the decline in vision to aging changes or cataracts. Many may have lost contact with the dogs’ breeders, so do not report the problem.

As for any recessive mutation in which carriers are normal, the recommendation is to avoid breeding 2 carriers, so not to produce affected offspring and to gradually eliminate carriers from the breeding population. At this time, the frequency of the mutant allele in the U.S. is unknown, but given the likelihood of very low frequency and the characteristic phenotypic impact on affected dogs, it is a good candidate for elimination.

* “Dental defects” mentioned were tooth extractions and loose lower incisors in at least 2 of the affected dogs when they were older [2]. Kidney disease of at least one dog was not fully characterized. Since those conditions are common in older dogs, they may or may not be a feature of the syndrome.